<DOC>
	<DOCNO>NCT00032734</DOCNO>
	<brief_summary>The study design assess efficacy investigational drug call SR121463B ( vasopressin receptor antagonist ) treatment low level sodium blood associate Syndrome Inappropriate Antidiuretic Hormone Secretion ( SIADH ) . This double blind period study follow 2 open label extension study flexible dos satavaptan .</brief_summary>
	<brief_title>Efficacy SR121463B Patients With Syndrome Inappropriate Antidiuretic Hormone Secretion</brief_title>
	<detailed_description>This multicenter worldwide study 32 participate men woman aim figure whether SR121463B safe effective correct low level sodium blood subject SIADH . The participation study last 34 day . After screen , first part study ( maximum 5 day ) , subject receive either capsule SR121463B match placebo . During second part study ( 23 day ) , subject receive either capsule SR121463B treatment . The subject assess physical examination , electrocardiogram , blood sampling , urine collection . Women childbearing potential must approve method contraception .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Hyponatremia</mesh_term>
	<mesh_term>Inappropriate ADH Syndrome</mesh_term>
	<mesh_term>Diabetes Insipidus</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Vasopressins</mesh_term>
	<mesh_term>Arginine Vasopressin</mesh_term>
	<mesh_term>Satavaptan</mesh_term>
	<criteria>SIADH origin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>Low Blood Sodium ( Hyponatremia )</keyword>
	<keyword>SIADH</keyword>
	<keyword>Inappropriate ADH Syndrome</keyword>
</DOC>